|
Atomistry » Fluorine » PDB 3l8v-3lxp » 3lfq | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Fluorine » PDB 3l8v-3lxp » 3lfq » |
Fluorine in PDB 3lfq: Crystal Structure of CDK2 with SAR60, An Aminoindazole Type InhibitorEnzymatic activity of Crystal Structure of CDK2 with SAR60, An Aminoindazole Type Inhibitor
All present enzymatic activity of Crystal Structure of CDK2 with SAR60, An Aminoindazole Type Inhibitor:
2.7.11.22; Protein crystallography data
The structure of Crystal Structure of CDK2 with SAR60, An Aminoindazole Type Inhibitor, PDB code: 3lfq
was solved by
M.K.Dreyer,
K.U.Wendt,
S.Schimanski-Breves,
P.Loenze,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Crystal Structure of CDK2 with SAR60, An Aminoindazole Type Inhibitor
(pdb code 3lfq). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 2 binding sites of Fluorine where determined in the Crystal Structure of CDK2 with SAR60, An Aminoindazole Type Inhibitor, PDB code: 3lfq: Jump to Fluorine binding site number: 1; 2; Fluorine binding site 1 out of 2 in 3lfqGo back to Fluorine Binding Sites List in 3lfq
Fluorine binding site 1 out
of 2 in the Crystal Structure of CDK2 with SAR60, An Aminoindazole Type Inhibitor
Mono view Stereo pair view
Fluorine binding site 2 out of 2 in 3lfqGo back to Fluorine Binding Sites List in 3lfq
Fluorine binding site 2 out
of 2 in the Crystal Structure of CDK2 with SAR60, An Aminoindazole Type Inhibitor
Mono view Stereo pair view
Reference:
D.Lesuisse,
G.Dutruc-Rosset,
G.Tiraboschi,
M.K.Dreyer,
S.Maignan,
A.Chevalier,
F.Halley,
P.Bertrand,
M.C.Burgevin,
D.Quarteronet,
T.Rooney.
Rational Design of Potent GSK3BETA Inhibitors with Selectivity For CDK1 and CDK2. Bioorg.Med.Chem.Lett. V. 20 1985 2010.
Page generated: Wed Jul 31 20:29:36 2024
ISSN: ISSN 0960-894X PubMed: 20167481 DOI: 10.1016/J.BMCL.2010.01.114 |
Last articlesZn in 9JPJZn in 9JP7 Zn in 9JPK Zn in 9JPL Zn in 9GN6 Zn in 9GN7 Zn in 9GKU Zn in 9GKW Zn in 9GKX Zn in 9GL0 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |